ALPS Advisors’s Pliant Therapeutics PLRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-45,261
| Closed | -$61.1K | – | 1053 |
|
|
2025
Q1 | $61.1K | Sell |
45,261
-3,949
| -8% | -$5.33K | ﹤0.01% | 986 |
|
|
2024
Q4 | $648K | Buy |
49,210
+972
| +2% | +$12.8K | ﹤0.01% | 567 |
|
|
2024
Q3 | $541K | Buy |
48,238
+1,164
| +2% | +$13K | ﹤0.01% | 596 |
|
|
2024
Q2 | $506K | Buy |
47,074
+4,589
| +11% | +$49.3K | ﹤0.01% | 574 |
|
|
2024
Q1 | $633K | Buy |
42,485
+1,423
| +3% | +$21.2K | ﹤0.01% | 565 |
|
|
2023
Q4 | $744K | Sell |
41,062
-3,117
| -7% | -$56.4K | 0.01% | 546 |
|
|
2023
Q3 | $766K | Buy |
44,179
+696
| +2% | +$12.1K | 0.01% | 531 |
|
|
2023
Q2 | $788K | Buy |
43,483
+11,361
| +35% | +$206K | 0.01% | 536 |
|
|
2023
Q1 | $854K | Sell |
32,122
-951
| -3% | -$25.3K | 0.01% | 502 |
|
|
2022
Q4 | $639K | Buy |
+33,073
| New | +$639K | 0.01% | 546 |
|